Blood Pressure Control Target in Diabetes

NACompletedINTERVENTIONAL
Enrollment

12,821

Participants

Timeline

Start Date

February 24, 2019

Primary Completion Date

May 31, 2024

Study Completion Date

September 15, 2024

Conditions
Blood Pressure Control Target in Diabetes
Interventions
OTHER

Treatment strategy regarding different systolic BP goals

The trial will test a treatment strategy question regarding different systolic BP goals and not test specific medications. Therefore, the BP treatment protocol is flexible in terms of the choice and doses of anti-hypertensive medications as long as systolic BP levels are within targets (\<120 mmHg in the intensive arm and \<140 mmHg in the standard arm).

Trial Locations (1)

200025

Ruijin hospital, Shanghai Jiaotong University School of Medicine, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT03808311 - Blood Pressure Control Target in Diabetes | Biotech Hunter | Biotech Hunter